PXS.AX Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 Dez 2023 @ 00:06):

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide...

Stats
Tagesvolumen	304
Durchschnittsvolumen	176 420
Marktkapitalisierung	20.23M
EPS	$-0.00850 ( Q1 \| 2023-09-30 )
Nächstes Ertragsdatum	( $0 ) 2024-07-29
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.400 (Sector) 0 (Industry) 0
ATR14	$0.00100 (5.26%)

ACW.AX 34.78%

ADO.AX 0.00%

AGH.AX -4.17%

ANP.AX -4.92%

ATH.AX 0.00%

AVE.AX 0.00%

BIT.AX 2.70%

BNO.AX -10.00%

BOT.AX -5.48%

CAN.AX 0.00%

CPH.AX 0.00%

CSL.AX 0.02%

CTE.AX 8.77%

CUV.AX 0.85%

CYP.AX 1.72%

DXB.AX 0.00%

ECS.AX 0.00%

EOF.AX -6.25%

GSS.AX 1.41%

IDT.AX 0.00%

IMC.AX 0.00%

IMM.AX -11.94%

IMU.AX 5.56%

IXC.AX -10.45%

KZA.AX 9.59%

LCT.AX 7.14%

LGP.AX -9.52%

MSB.AX 1.02%

MVP.AX -1.22%

MXC.AX 2.44%

NEU.AX 3.15%

NOX.AX -2.94%

NSB.AX 2.56%

OCC.AX 0.00%

OPT.AX -2.78%

OSL.AX 0.00%

PAA.AX 0.00%

PAB.AX 0.00%

PAR.AX -1.92%

PBP.AX 0.00%

PIQ.AX -2.22%

PTX.AX -2.56%

PXS.AX 3.70%

PYC.AX 0.00%

RAC.AX 1.11%

RCE.AX 5.26%

SPL.AX 9.20%

TLX.AX 1.36%

VBS.AX 0.00%

Volumen Korrelation

Lang: -0.28 (neutral)

Kurz: -0.94 (very strong negative)

Signal:(26.307) Possible Trading Opportunity Present (swing)

Pharmaxis Ltd Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Pharmaxis Ltd Korrelation - Währung/Rohstoff

0.62
( weak )

-0.60
( weak negative )

0.00
( neutral )

-0.54
( weak negative )

Pharmaxis Ltd Finanzdaten

Annual	2022
Umsatz:	$5.77M
Bruttogewinn:	$3.06M (53.06 %)
EPS:	$-0.0173

FY	2022
Umsatz:	$5.77M
Bruttogewinn:	$3.06M (53.06 %)
EPS:	$-0.0173

FY	2022
Umsatz:	$7.43M
Bruttogewinn:	$7.43M (100.00 %)
EPS:	$0.0205

FY	2021
Umsatz:	$6.68M
Bruttogewinn:	$6.68M (100.00 %)
EPS:	$-0.00700

Financial Reports:

No articles found.

Pharmaxis Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Pharmaxis Ltd

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma. The company's product pipeline consists of oral pan-lysyl oxidase inhibitors (LOX) targeting myelofibrosis and other cancers; topical pan-LOX inhibitors targeting skin scarring after events, such as accidents, surgery,and burns; selective Lysyl Oxidase Like Inhibitors (LOXL2) targeting chronic fibrotic diseases, including kidney fibrosis, pulmonary fibrosis, liver fibrosis, and cardiac fibrosis; and semicarbazide-sensitive amine oxidase for neuro inflammatory diseases. It is also developing Orbital, a dry powder inhaler to deliver high drug doses to lungs. Pharmaxis Ltd was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.